Based on these results we further checked differences of total mucosal tissue macrophages, mast cells, and CD8 + T-cells (per RBM length) between ACO and asthma groups without ICS and with ICS-treated patients (Fig. 13a). The gene discussed is CD8A; the disease is asthma.